OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator. This document is also available as Markdown.

2025-03-31-accounts

THE MARY HOW TRUST FOR CANCER PREVENTION

Annual Report

and Audited Financial Statements

for the year ended 31 March 2025

Registered Charity Number 1122393 Registered Company Number 06324356

THE MARY HOW TRUST FOR CANCER PREVENTION

AUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

INDEX

Page
Charity information 1
Chair’s statement 2
Welcome from the Chief Executive 3
Trustees’ report 4
Auditor’s report 11
Statement of financial activities 14
Balance sheet 15
Statement of cash flow 16
Accounting policies 17
Notes to the financial statements 20

THE MARY HOW TRUST FOR CANCER PREVENTION

AUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

CHARITY INFORMATION

Trustees

J A Ross J H Barder M C Wratten (Resigned 24 June 2024) D P Mathieson C Meeking N Stanbury C Scaramanga J H G Ellis (Resigned 17 March 2025) T Morley (Appointed 20 May 2025) N M Neal-Smith Chair (Appointed 01 September 2025) I L Lloyd (Appointed 09 October 2025)

Registered & Principal office Unit 1 & 2 The Colonnades 17 London Road Pulborough West Sussex RH20 1AS

Registered charity number 1122393

Registered company number 06324356

Auditor

Blue Spire Limited Cawley Priory South Pallant Chichester West Sussex PO19 1SY

Investment advisor

Quilter Cheviot Senator House 85 Queen Victoria Street London EC4V 4AB

Page 1

AUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

THE MARY HOW TRUST FOR CANCER PREVENTION

CHAIR’S STATEMENT

I am pleased to present the annual report and financial statements for The Mary How Trust for Cancer Prevention (‘The Mary How Trust’) for the year ended 31 March 2025. It has been another extremely successful year for our charity.

The Trust has continued to grow achieving more than 3700 screenings in the year, an increase of 900 on 2023/24, and close to the full capacity of the Colonnades. This has resulted in the early detection of more potential diseases offering the possibility of improved outcomes for those effected. This growth in screening numbers is also reflected in a surplus, which includes legacy contributions, donations, fund raising and our Charity Shop.

Another notable accomplishment for the year has been the establishment of the Medical Advisory Board (MAB). This group of medical professionals will provide oversight and guidance to the Trust’s clinical operations, helping to improve both the effectiveness and efficiency of the service we offer.

During the year we have been actively searching for an appropriate second site so that we can significantly grow our client base in another area, in line with the Trust’s aim to provide access to our unique service to as wide a group as possible. This has proved to be more difficult than we first expected. However, it is important that we choose the right site and are hopeful that we will identify somewhere soon.

The last year has also seen some notable Trustee changes. After 10 years as Finance Director, James Ross will retire at the next Annual General Meeting. We would like to express our heartfelt thanks to James not only for his diligent work as finance director but also for his considerable efforts in facilitating the move to the Colonnades and the current search for new premises. The Board would also like to thank John Ellis who has stepped aside as Chair and Trustee, for his contributions to the Trust.

I am delighted to have joined The Mary How Trust this year and to have taken on the role of Chair. It is a privilege to be part of such a dedicated and compassionate organisation whose work makes a tangible difference to people’s lives. The Trust’s commitment to early detection and prevention – offering high-quality health screening regardless of ability to pay – is both inspiring and vital. I am excited to build on the strong foundations laid by my predecessors and to work alongside our talented team, Trustees, and volunteers as we continue to expand our reach and impact in the years ahead.

We are as always, immensely grateful to all those who continue to support our remarkable charity. In particular, the Trustees would like to thank our staff and volunteers led by Lynda Vowles, our exceptional CEO. Thanks to their efforts, we continue to develop our service and are entering an exciting time with the opportunity for significant expansion thereby improving the health outcomes for a wider group of people.

Nicky Neal-Smith Chair of Trustees Dated: 24 November 2025

Page 2

AUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

THE MARY HOW TRUST FOR CANCER PREVENTION

WELCOME FROM THE CHIEF EXECUTIVE

As we close the financial year ending 31 March 2025, I’m proud to look back on what has been a remarkable and inspiring year for The Mary How Trust. Together, we have reached more people, strengthened our services, and taken meaningful steps toward a healthier future for our communities.

This year, we carried out 3,793 health screenings—exceeding our target and reaffirming our belief that everyone deserves access to life-saving, preventative health checks, regardless of their financial situation. Thanks to our donation-based model, we continue to make early detection accessible to all adults, helping people take charge of their health and their futures.

We are excited to be preparing for a second premises, with lease negotiations now underway. Once open, this new site will enable us to provide additional screenings each year, reducing waiting times and helping even more people in our local communities benefit from timely health checks.

Our veterans’ pilot programme has already shown encouraging outcomes, and with further funding, we hope to expand this initiative in the coming year. Our partnership with Surrey and Sussex Police is also progressing well, with pilot screenings due to begin in the first half of the new financial year.

The establishment of our Medical Advisory Board (MAB) marks another major milestone. Bringing together respected professionals from across medical disciplines, the Board provides expert guidance to strengthen our clinical standards and ensure our services remain evidence-based, effective, and responsive to evolving health screening needs.

None of these achievements would be possible without the dedication and passion of our staff, volunteers, trustees, and supporters. Every person who gives their time, energy, or donations plays a vital role in helping us save lives through early detection and prevention.

We are truly grateful for your ongoing support, which allows us to help more people take control of their health and access our vital screenings. Together, we really are making a difference.

Lynda Vowles

Chief Executive Officer

Page 3

THE MARY HOW TRUST FOR CANCER PREVENTION

AUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

TRUSTEES’ REPORT

The Trustees, who are directors for the purposes of company law, present their report and financial statements for the year ended 31 March 2025.

The financial statements have been prepared in accordance with the accounting policies, set out in notes to the accounts and comply with the charity's governing document, the Companies Act 2006, the Charities Act 2011 and Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (as amended for accounting periods commencing from 1 January 2019).

Since the charitable company qualifies as small under section 382, the strategic report required of medium and large companies under The Companies Act 2006 (Strategic Report and Director's Report) Regulations 2013 is not required.

Objectives and activities

The objects of the charitable company as set out in its Memorandum and Articles of Association are:

Activities for achieving objectives

We deliver comprehensive health screening and wellness consultations to self-referred, asymptomatic adults aged 18 and over. Our services include nurses’ consultation, ultrasound scans and detailed health reports, which are shared with clients and, with consent, their GPs.

Our donation-based model ensures accessibility for all, supported by income from our charity shop, fundraising events, grants, and legacies. We have expanded our facilities and clinical team to meet growing demand and help reduce waiting times.

Our team included two full-time and seventeen part-time staff, supported by dedicated volunteers. The charity shop, also based in Pulborough, operates six days a week and plays a vital role in funding our services.

The Board of Trustees has considered the guidance provided by the Charity Commission when determining the activities that the charity should undertake.

Main activities undertaken to further the charity's purposes for the public benefit

The Board of Trustees ensures that all activities align with the Charity Commission’s guidance on public benefit. Our charitable services are designed to deliver meaningful health outcomes and empower individuals to take control of their well-being.

We deliver screenings on a donation basis, ensuring accessibility for all. Our operational costs are supported through diversified income streams, including our charity shop, fundraising, donations and legacy giving.

We actively collaborate with local GPs, other charities and community organisations to ensure continuity of care and promote health awareness. Our services are inclusive and non-discriminatory, reaching individuals from all walks of life.

Relationships with other organisations

We continue to strengthen partnerships with other charities, healthcare providers, and community groups. Our collaboration with Veterans Outreach Support has grown and saw a pilot scheme during the year. A collaboration with Surrey and Sussex Police is progressing, with pilot screenings scheduled for early 2025/26. These relationships are key to expanding our reach and enhancing service delivery.

Page 4

AUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

THE MARY HOW TRUST FOR CANCER PREVENTION

TRUSTEES’ REPORT

Environmental impact

We prioritise sustainability through energy-efficient procurement, paperless operations – wherever possible, and recycling initiatives. Our charity shop contributes to a circular economy by repurposing unsaleable goods. Staff are actively engaged in promoting eco-friendly practices, and our Environmental Policy is reviewed annually.

Achievements and performance

2024/2025 in Summary

The year 2024/25 brought significant change both at home and abroad. Here in the UK, the new government’s first months in office marked a period of adjustment and anticipation. The Chancellor, Rachel Reeves, set out her first Budget, focused on rebuilding public services and boosting economic growth. However, changes to public spending and employer National Insurance contributions created new pressures for many charities, including ours.

Inflation reached 3.6% in the autumn, and while it has since eased, interest rates remained high for much of the year— driving up operational costs for organisations across the voluntary sector.

Globally, uncertainty continued to shape the economic landscape. The election of Donald Trump as US President brought renewed trade tensions, with increased tariffs contributing to higher import prices and supply chain costs. Ongoing conflicts, climate-related crises, and humanitarian challenges also continued to influence donor behaviour and funding patterns worldwide.

In this complex environment, demand for charitable services grew—often outpacing available resources. Yet, despite these challenges, The Mary How Trust remained focused on our mission of early detection and prevention.

Over the past twelve months, we have:

We appointed Blue Spire as our new accountants to guide us through our transition to full audit requirements, following our turnover exceeding £1 million—a milestone that reflects both our growth and the trust placed in our work.

Throughout another year of change and challenge, The Mary How Trust has continued to adapt, evolve, and deliver. Thanks to the steadfast support of our community, staff, volunteers, and partners, we remain on a strong path toward a healthier future for all.

Financial review

Going concern

The Trustees have a reasonable expectation that the charity has sufficient resources to continue operating for the foreseeable future. This is supported by strong financial management, diversified income streams, and robust reserves. The going concern basis remains appropriate for preparing the financial statements.

Investment policy

All investments are now held with Quilter Cheviot, split between the Global Income & Growth Fund for Charities and short-term Money Market Bonds. Monthly monitoring and quarterly reviews are conducted to ensure alignment with our objectives and risk profile.

Page 5

AUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

THE MARY HOW TRUST FOR CANCER PREVENTION

TRUSTEES’ REPORT

Principal risks and uncertainties

Key risks include economic volatility, inflation, and changes in government policy. Adjustments to employer National Insurance and broader tax reforms have increased operational costs. Global instability and weak business sentiment have also affected donor behaviour and funding availability.

We monitor regulatory changes from the Care Quality Commission, Charity Commission, and GDPR legislation. Internal controls have been reviewed using the Charity Commission’s CC8 checklist and found to be robust.

Reserves

We maintain reserves equivalent to at least nine months of budgeted expenditure, currently £904,000 for the year 2025/26. This ensures financial stability and supports our strategic growth. The Board reviews the policy annually and monitors reserves on a monthly basis.

Review 2024/2025

The 2024/25 financial year was shaped by economic uncertainty, rising costs, and growing demand for charitable services. In this context, The Mary How Trust delivered a strong financial performance, enabling us to continue expanding access to life-saving health screenings and planning for future growth.

Total funds increased to £1,797,311 (2024: £983,00), with £352 (2024 £1,905) allocated for restricted purposes. This reflects both careful financial management and the generosity of our supporters. After accounting for funds designated for Fixed Assets, Intangible Assets, and Restricted Funds our Free Reserves stand at £903,415 (2024: £379,246), providing a solid foundation to maintain our services and respond to emerging needs.

During the year, we sold our M&G Charibonds and transferred the funds to Quilter Cheviot, ensuring continued growth and security of our investments. Day-to-day liquidity is maintained through cash holdings with Barclays Bank PLC, allowing us to meet operational requirements with confidence.

Our charity shop continued to perform strongly, providing not only essential income but also a visible presence in the community and an opportunity for supporters to engage directly with our work.

We are deeply grateful for a generous legacy received this year, which will help bring our ambitious plans for expansion to fruition.

Despite the financial pressures faced by many organisations this year, careful planning, prudent investment decisions, and the dedication of our supporters have allowed The Mary How Trust to remain financially resilient. These resources will underpin our ongoing mission to deliver accessible, preventative health screening services and support the expansion of our programmes in the coming year.

Plans for future periods

Community Engagement

We will deepen our engagement with the community, raising awareness of the importance of early detection and prevention. Outreach efforts will focus on underserved populations and promoting health education.

Financial Growth

With turnover now exceeding £1 million, we are subject to full audit requirements. We remain focused on securing sustainable funding to support our expanding services and ensure long-term financial resilience.

Page 6

THE MARY HOW TRUST FOR CANCER PREVENTION

AUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

TRUSTEES’ REPORT

Commitment to Growth

We are committed to increasing our screening capacity and plan to open a second premises in 2026. This expansion will allow us to reach more individuals and help reduce waiting times, ensuring equitable access to our services.

Risk Mitigation

We continue to monitor economic, regulatory, and operational risks closely. Our systems for risk identification and mitigation are robust and regularly reviewed. These include a comprehensive risk management matrix and a business continuity plan, both of which are standing items on our Trustee meeting agendas.

Key Objectives for the Future

Capacity Expansion

We anticipate reaching a full capacity of approximately 4,000 screenings by the end of the next financial year. Exciting plans for a second site are progressing well—a suitable property has been identified, to the north of our area, and lease negotiations are underway. Once fully operational, this new facility will enable up to 10,000 additional screenings annually, helping to reduce waiting times and expand access to preventative health services across our communities. Full capacity is expected to be achieved over the next five years.

Community Awareness

Raising awareness of our services and the importance of early detection remains a top priority. We will continue to deliver outreach campaigns that engage underserved populations, promote health education, and empower people to take charge of their health.

Accessibility and Inclusivity

We are committed to ensuring our services are accessible to all adults, regardless of geography, background, or financial means. Special focus will be placed on supporting disadvantaged and underrepresented groups, with tailored outreach and additional support where needed.

Service Enhancement

Our Medical Advisory Board (MAB) is now fully active, guiding our clinical strategy and supporting service development. Drawing on expertise across oncology, general practice, diagnostics, and public health, the MAB helps ensure our screening programmes remain evidence-based, innovative, and responsive to emerging health screening trends.

Data Utilisation

We will continue to use anonymised data to inform our marketing, brand development, and service improvement strategies, always in full compliance with GDPR regulations. During the year, we were delighted to undergo the Cyber Essentials audit, achieving certification and reinforcing our commitment to data security and privacy.

Healthcare Professional Collaboration

We continue to strengthen relationships with local healthcare professionals, charities, and community organisations. The MAB plays a central role in these partnerships, providing expert oversight and helping us maintain alignment with best practice in preventative health screening.

Looking to the Future

The Mary How Trust is poised to make an even greater impact in the years ahead. With expanded screening capacity, a second premises, and growing partnerships, we will be able to reach more people and save more lives through the early detection of cancer and other life-limiting illnesses.

Page 7

THE MARY HOW TRUST FOR CANCER PREVENTION

AUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

TRUSTEES’ REPORT

Our second premises will play a crucial role in reducing waiting times and ensuring equitable access to our services across the region. The veterans’ pilot screening programme has already demonstrated strong outcomes, and with anticipated funding, we aim to expand this initiative in 2025/26. Collaborations with Surrey and Sussex Police are progressing well, with pilot screenings scheduled to launch in the second quarter of the new financial year.

Conclusion

The Mary How Trust is excited about the opportunities ahead. Building on our strong foundations, we will continue to develop innovative programmes, strengthen partnerships, and extend our reach into communities that need us most.

We will focus on enhancing the experience for everyone using our services, improving engagement and support, and exploring new ways to educate and empower the public about the importance of early detection. By nurturing collaborations with local healthcare professionals, community groups, and other organisations, we aim to create a more connected, informed, and healthy community.

As we look ahead, our commitment remains unwavering: to provide inclusive, high-quality health screening and to make a tangible difference in the lives of those we serve.

Structure, governance and management

Constitution

The Mary How Trust, founded in June 1988, is a charitable company limited by guarantee, incorporated on 25 July 2007. It is governed by the Memorandum and Articles of Association of the charitable company and is controlled by a board of trustees whose members are elected at the Annual General Meeting and are directors for the purposes of company law and trustees for the purposes of charity law. Registered charity number 1122393; Company Registration No: 06324356.

The vision, mission and values of The Mary How Trust guide us and remain as important today as they were when the charity was first formed back in 1988.

Appointment and Election of Trustees

The strategic leadership of our charity rests with our dedicated Trustees, each contributing their unique knowledge, skills, and passion to advance the charity's mission. They bear the critical responsibility of steering the charity, ensuring its continued growth and impact. Guided by the provisions outlined in the Articles of Association, our Trustees, whether elected or co-opted, possess the authority to appoint new Directors/Trustees, when necessary, thus reinforcing our commitment to the charity's long-term success.

Induction and Training of Trustees

In alignment with the Charity Commission's guidance on trustees' induction and training, our Board places great emphasis on recruiting trustees with specific skills that can significantly contribute to the charitable company. Prospective trustees or directors are required to initiate their engagement by writing to the Chair of the Board and providing a comprehensive curriculum vitae. To support their integration, we provide a Trustee Information Pack and facilitate initial discussions, followed by interviews. Newly appointed trustees undertake a probationary period before their formal confirmation, which is ratified at the next scheduled Annual General Meeting (AGM).

In adherence to regulatory requirements and good governance principles, all new trustees undergo an induction process. This includes providing detail of their legal obligations under charity and company law, as well as familiarity with the contents of the Memorandum and Articles of Association. Additionally, we ensure that they are well-informed about the committee structure, decision-making processes, and the recent financial performance of the charity. To further enhance their knowledge, they are provided with the Charity Commission booklet 'CC3': 'The Essential Trustee'. We also encourage our Trustees to engage in relevant external and online training events, which are financially supported by the charity, enhancing their effectiveness in fulfilling their roles.

Page 8

THE MARY HOW TRUST FOR CANCER PREVENTION

AUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

TRUSTEES’ REPORT

Trustees do not hold any beneficial interest in the company and all of them are members of the company. We believe that good governance is fundamental to our success and take our trustee responsibilities seriously.

Our organisational structure and decision-making processes are continually reviewed by the Board of Trustees. The Board convenes six times a year to discuss and determine the charity's direction. In addition, we have an Investment Committee, whilst financial controls are entrusted to the Finance Director.

Trustee meetings follow a structured agenda that includes standing items such as comprehensive management account reporting, risk assessments, health and safety considerations, incident management, and safeguarding. Additionally, we engage subgroups as needed. The day-to-day management of the charity is delegated to Lynda Vowles, the CEO, and the Senior Management Team.

We are committed to active risk management, addressing the major risks to which the charity may be exposed. Our systems are designed to mitigate these risks, incorporating a risk management matrix and a business continuity plan, both of which undergo regular reviews. Risk is a recurring agenda item at the Trustee meetings.

The charity operates under the oversight of regulatory bodies, including the Charity Commission, Companies House, and the Care Quality Commission.

Personnel

During the year, we experienced change in our leadership team. Our Chair, John Ellis, stepped down due to personal family matters. We extend our sincere thanks to John for his guidance, dedication, and service. We wish him well. Recruitment of a new Chair, Nicola Neal-Smith, has been completed, and we look forward to welcoming them in the next financial year. Mary Wratten retired from the Board in June 2024 after ten years of dedicated service. During her tenure, she played a pivotal role in advancing the charity’s mission, and the Board extends its deepest gratitude for her outstanding contribution. We are pleased that Mary continues to support the organisation in a voluntary capacity. James Ross, our Finance Trustee, will be stepping down at the AGM in November after ten years of dedicated service. We are deeply grateful for his commitment and valuable contribution over the past decade. Tim Morley has been appointed to succeed James in this role and will be shadowing him in the coming months to ensure a smooth handover. We also look forward to Ian Lloyd joining the board in the new financial year.

We said a heartfelt farewell to Sarah Ross, our Charity Shop Manager, who left due to health reasons. Sarah had been with the charity for ten years and was instrumental in making the shop a thriving hub within the community. Her keen eye for donations, skill in pricing, and commitment to customer service significantly increased revenue and strengthened the shop’s role as a welcoming, inclusive space. Sarah’s warmth, expertise, and dedication will be deeply missed by both the team and the wider community.

The Mary How Trust remains committed to attracting and retaining a skilled, motivated, and supported workforce. We prioritise clear communication, professional development, and performance management. Regular supervision, reviews, and open dialogue ensure that our team is aligned with the charity’s strategic goals and empowered to thrive in their roles.

Our management team comprises the Chief Executive Officer, Practice Manager/Head of Operations, Lead Health & Wellbeing Screening Nurses, Ultrasound Lead, Charity Shop Manager, and Accounts Lead. Volunteers continue to play a vital role, supporting administration, fundraising, and charity shop operations, and are an essential part of our success.

Remuneration and Diversity

We ensure that remuneration for key personnel is fair, competitive, and in line with sector standards. Salaries are reviewed regularly to reflect evolving responsibilities and market conditions, ensuring our team is recognised and rewarded appropriately.

Equally, we are committed to fostering a diverse, inclusive, and supportive workplace, where all individuals are valued and empowered to contribute fully—regardless of background, identity, or circumstance. This commitment underpins our culture and helps us deliver the highest-quality services to the communities we serve.

Page 9

AUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

THE MARY HOW TRUST FOR CANCER PREVENTION

TRUSTEES’ REPORT

Trustees' responsibilities statement

The trustees (who are also directors of The Mary How Trust for Cancer Prevention for the purposes of company law) are responsible for preparing the Trustees’ Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company law requires the trustees to prepare financial statements for each financial year. Under company law the trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that period. In preparing these financial statements, the trustees are required to:

The trustees are responsible for keeping adequate accounting records that disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

In so far as the trustees are aware:

The trustees are responsible for the maintenance and integrity of the corporate and financial information included on the charitable company's website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.

Appointment of Auditor

Blue Spire has expressed its willingness to stand for reappointment as the charity’s auditors. A resolution proposing their reappointment will be put forward at the Annual General Meeting.

The Trustees’ Report was approved by the Board of Trustees.

--------------------------------N Neal-Smith

Trustee 02 December 2025 Dated ……………………..

Page 10

AUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

THE MARY HOW TRUST FOR CANCER PREVENTION

AUDITOR’S REPORT

Independent Auditor’s Report to the Trustees of The Mary How Trust for Cancer Prevention

Opinion

We have audited the financial statements of The Mary How Trust for Cancer Prevention (the ‘charitable company’) for the year ended 31 March 2025 comprise Statement of Financial Activities, the Balance Sheet, the Statement of Cash Flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the auditor responsibilities for the audit of the financial statements section of our report. We are independent of the charitable company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Other matter

The financial statements of the charity for the year ended 31 March 2024 were not audited but independently examined by another firm. Accordingly, we make no overall comment nor draw any conclusions in respect of the year to 31 March 2024, undertaking necessary work to satisfy ourselves of the opening balance positions of the charity. Through this work we identified an apparent understatement of the charity’s investment holding market value which has been aligned through change in market value in the current year. It was considered not worthwhile to include a prior year restatement in respect of this.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the trustees’ use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charitable company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the trustees' report, other than the financial statements and our auditor’s report thereon. The trustees are responsible for the other information. Our opinion on the financial statements does not cover the other information and we do not express any form of assurance conclusion thereon.

Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Page 11

AUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

THE MARY HOW TRUST FOR CANCER PREVENTION

AUDITOR’S REPORT

Matters on which we are required to report by exception

We have nothing to report in respect of the following matters in relation to which the Charities (Accounts and Reports) Regulations 2008 require us to report to you if, in our opinion:

Responsibilities of trustees

As explained more fully in the trustees’ responsibilities statement [set out on page …], the trustees (who are also the directors of the charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the trustees are responsible for assessing the charitable company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the charitable company or to cease operations, or have no realistic alternative but to do so.

Auditor responsibilities for the audit of the financial statements

We have been appointed as auditor under section 144 of the Charities Act 2011 and report in accordance with the Act and relevant regulations made or having effect thereunder.

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.

Page 12

THE MARY HOW TRUST FOR CANCER PREVENTION

AUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

AUDITOR’S REPORT

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

Use of our report

This report is made solely to the charitable company’s trustees, as a body, in accordance with Part 4 of the Charities (Accounts and Reports) Regulations 2008. Our audit work has been undertaken so that we might state to the charitable company’s trustees those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and the charitable company’s trustees as a body, for our audit work, for this report, or for the opinions we have formed.

Blue Spire Limited Statutory Auditor

Date 02 December 2025

Blue Spire Limited is eligible for appointment as auditor of the charity by virtue of its eligibility for appointment as auditor of a company under section 1212 of the Companies Act 2006.

Page 13

THE MARY HOW TRUST FOR CANCER PREVENTION

AUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

STATEMENT OF FINANCIAL ACTIVITIES (INCLUDING INCOME AND EXPENDITURE ACCOUNT)

Note
INCOME AND ENDOWMENTS FROM:
Donations and legacies
1
Other trading activities
2
Investments
3
Total income and endowments
EXPENDITURE ON:
Raising funds
4
Charitable activities
5
Total exependiture
Net gains/(losses on investments)
12
Net Income/(expenditure)
Transfers between funds
17
Net movement in funds
RECONCILIATION OF FUNDS
Total funds brought forward
16, 17
Total funds carried forward
16, 17
Unrestricted
Funds
£
1,472,841
134,730
43,319
1,650,890
92,109
749,848
841,957
7,287
816,220
(4)
816,216
981,095
1,797,311
Restricted
Funds
£
645
-
-
645
312
1,890
2,202
-
(1,557)
4
(1,553)
1,905
352
2025
Total
Funds
£
1,473,486
134,730
43,319
1,651,535
92,421
751,738
844,159
7,287
814,663
-
814,663
983,000
1,797,663
2024
Total
Funds
£
853,171
121,463
21,948
996,582
91,733
674,356
766,089
34,170
264,663
-
264,663
718,337
983,000

The statement of financial activities includes all gains and losses recognised during the year. All of the above results are derived from continuing activities.

Page 14

THE MARY HOW TRUST FOR CANCER PREVENTION

AUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

BALANCE SHEET AS AT 31 MARCH 2025

2025 2024
Note £ £ £ £
FIXED ASSETS
Tangible assets 11 43,896 56,443
Investments 12 1,563,880 604,565
1,607,776 661,008
CURRENT ASSETS
Debtors 13 4,327 7,033
Current Investments 14 173,448 165,406
Cash at hand and in bank 91,359 182,057
Total current assets 269,134 354,496
CURRENT LIABILITIES
Creditors: amounts falling due within one year 15 (79,247) (32,504)
Net current assets/(liabilities) 189,887 321,992
Net assets/(liabilities) 1,797,663 983,000
THE FUNDS OF THE CHARITY
Restricted funds 17 352 1,905
Designated funds 893,896 545,406
General Funds 903,415 435,689
Unrestricted funds 17 1,797,311 981,095
Total charity funds 1,797,663 983,000

For the year ended 31 March 2025 the charity was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The trustees acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

The financial statements were approved and authorised for issue by the trustees and signed on their behalf by:

02 December 2025

…………………………………………. N Neal-Smith Trustee

…...........................

Date

The Mary How Trust for Cancer Prevention Registered Charity Number 1122393 Registered Company Number 06324356

Page 15

THE MARY HOW TRUST FOR CANCER PREVENTION

AUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

STATEMENT OF CASH FLOWS

£
£
Net cash flow from operating activities (see below)
826,434
Cash flow from investing activities
Payments to acquire tangible fixed assets
(381)
Payments to acquire fixed asset investments
(1,132,908)
Proceeds on sale of investments
183,917
Investment income
43,319
Net cash flow from investing activities
(906,053)
Net increase/(decrease) in cash and cash equivalents
(79,619)
Cash and cash equivalents brought forward
347,463
Cash and cash equivalents carried forward
267,844
Cash and cash equivalents consist of:
Cash at bank and in hand
91,359
Cash held within investment portfolio
3,037
Short term deposits
173,448
Cash and cash equivalents at 31 March
267,844
Reconciliation of net income to net cash flow from operating activities
£
£
Net income for the year
814,663
Adjusted for:
Investment income
(43,319)
(Gains)/losses on investments
(7,287)
Depreciation and impairment of tangible fixed assets
12,928
Decrease/(increase) in accrued investment income
-
Decrease/(increase) in debtors
2,706
Increase/(decrease) in creditors
46,743
11,771
826,434
2025
2025
£
£
192,776
(125,000)
-
27,354
(97,646)
95,130
252,333
347,463
182,057
-
165,406
347,463
£
£
264,663
(21,948)
(34,170)
12,805
(5,406)
5,677
(28,845)
(71,887)
192,776
2024
2024
£
£
192,776
(125,000)
-
27,354
(97,646)
95,130
252,333
347,463
182,057
-
165,406
347,463
£
£
264,663
(21,948)
(34,170)
12,805
(5,406)
5,677
(28,845)
(71,887)
192,776
2024
2024
192,776

Page 16

THE MARY HOW TRUST FOR CANCER PREVENTION

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

ACCOUNTING POLICIES

General information, scope and basis of the financial statements

The Mary How Trust for Cancer Prevention is a private limited company, incorporated in England, limited by guarantee and has no share capital. In the event of the charity being wound up, the liability in respect of the guarantee is limited to £1 per member.

The registered office address of the charitable company is Units 1&2, The Colonnades, 17 London Road, Pulborough, West Sussex, England, RH20 1AS.

The charity constitutes a public benefit entity as defined by FRS 102. The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland issued in October 2019, the Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland (FRS 102), the Charities Act 2011, the Companies Act 2006 and UK Generally Accepted Accounting Practice.

The financial statements are prepared on a going concern basis under the historical cost convention, modified to include certain items at fair value. The financial statements are presented in sterling which is the functional currency of the charity and rounded to the nearest £.

The significant accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all years presented unless otherwise stated.

Going concern

The trustees haved considered relevant information, including the annual budget and the impact of subsequent events, in making their assessment.

Based on these assessments and having regard to the resources available to the entity, the trustees have concluded that there is no material uncedrtainty in relation to the appropriateness of continuing to adopt the going concern basis in preparing the annual report and accounts.

Fund accounting

Unrestricted funds are available for use at the discretion of the trustees in furtherance of their charitable objectives.

Designated funds comprise funds which have been set aside at the discrestion of the trustees for specific purposes.

Restricted funds are subject to specific conditions by donors or grantors as to how they may be used.

Further details of the use and purpose of each fund are disclosed in Notes 17 and 18.

Incoming resources

Income is recognised when the charity is legally entitled to it after any performance conditions have been met, the amounts can be measured reliably, and it is probable that income will be received. Cash donations are recognised on receipt. Other donations are recognised once the charity has been notified of the donation, unless performance conditions require deferral of the amount. Income tax recoverable in relation to donations received under Gift Aid or deeds of covenant is recognised at the time of the donation. Legacies are recognised on receipt or otherwise if the charity has been notified of an impending distribution, the amount is known, and receipt is expected. If the amount is not known, the legacy is treated as a contingent asset.

Grants are included in the statement of financial activities on a receivable basis. The balance of income received for specific purposes but not expended during the period is shown in the relevant funds on the balance sheet. Where income is received in advance of entitlement of receipt, its recongition is deferred and included in creditors as deferred income. Where entitlement occurs before income is received, the income is accrued.

Income tax recoverable in relation to investment income is recognised at the time of the investment income is receivable.

Resources expended

Expenditure is recognised as soon as there is a legal or constructive obligation committing the charity to make payment to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably.

Expenditure is classified by activity. The costs of each actiivty are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single acitivty are apportioned between those activities on a basis consistent with the use of resources. Central staff are allocated on the basis of time spent, and depreciation charges are allocated on the portion of the asset's use.

Page 17

THE MARY HOW TRUST FOR CANCER PREVENTION UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

ACCOUNTING POLICIES

Expenditure on raising funds includes all expenditure incurred by the company to raise funds for its charitable purposes and includes costs of all fundraising activities event and non-charitable trading.

Expedenditure on charitable activities is incurred on directly undertaking the activities whch further the company's objectives, as well as any associated support costs.

All expenditure is inclusive of irrecoverable VAT.

Fixed assets

Tangible fixed assets costing £10,000 or more are capitalised and recognised when future economic benefits are probable and the cost or value of the asset can be measured reliably.

Tangible fixed assets are initially measured at cost and subsequently measured at cost, net of depreciation and any impairment losses. All costs incurred to bring a tangible asset into its intended working condition should be included in the measurement of cost.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Leasehold improvements On a straight line basis, to the lease break date Plant and equipment 33.3% straight line basis Fixtures and fittings 33.3% straight line basis

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the statement of financial activities.

Fixed and current asset investments

Fixed asset investments are initially measured at transaction price excluding transaction costs, and are susequently measured at fair value at each reporting date. Changes in fair value are recognised in net income/(expenditure) for the year. Transaction costs are expensed as incurred.

Investment gains and losses, whether realised or unrealised, are combined and presented as 'Gains/(Losses) on investments' in the statement of financial activities.

Impairment of fixed assets

At each reporting end date, the charity reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).

Debtors and creditors receivable / payable within one year

Trade and other debtors are recognised at the settlement amount after any trade discounts offered. Prepayments are valued at the amount prepaid net of any trade discounts due.

Cash and cash equivalents

Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

VAT

The charity is not registered for VAT and is unable to recover VAT incurred. On this basis costs are recorded inclusive of VAT within the SOFA.

Taxation

The charity is considered to pass the tests set out in sections 521 to 536 Income Tax Act 2007 (ITA 2007), as such no income tax is payable on the charity's activities.

Page 18

THE MARY HOW TRUST FOR CANCER PREVENTION UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

ACCOUNTING POLICIES

Financial instruments

The charity has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instrument Issues' of FRS 102 to all of its financial statements.

Financial instruments are recognised in the charity's balance sheet when the charity becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforaceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitues a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities

Basic financial liabilities, including creditors and bank loans are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial laibilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of operations from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Employee benefits

The cost of any unused holiday entitlement is recongised in the period in which the employee's services are received.

Termination benefits are recognised immediately as an expense when the charity is demonstrably committed to terminate the employment of an employee tor to provide termination benefits

Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

Critical accounting estimates and judgements

In the application of the charity's accounting policies, the trustees are required to make judgments, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Page 19

THE MARY HOW TRUST FOR CANCER PREVENTION UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

NOTES TO THE FINANCIAL STATEMENTS

1. Donations and legacies

Donations and gifts
Legacies receivable
Grants
Other
Unrestricted
Funds
£
854,052
453,469
1,000
164,320
1,472,841
Restricted
Funds
£
645
-
-
-
645
2025
Total
Funds
£
854,697
453,469
1,000
164,320
1,473,486
Unrestricted
Restricted
Funds
Funds
£
£
624,077
8,540
100,000
-
-
3,289
117,265
-
841,342
11,829
2024
Total
Funds
£
632,617
100,000
3,289
117,265
853,171

2. Other trading activities

Fundraising events
Shop
Other
Unrestricted
Funds
£
17,429
102,567
14,734
134,730
Restricted
Funds
£
-
-
-
-
2025
Total
Funds
£
17,429
102,567
14,734
134,730
Unrestricted
Restricted
Funds
Funds
£
£
7,499
-
105,137
-
8,827
-
121,463
-
2024
Total
Funds
£
7,499
105,137
8,827
121,463

3. Income from investments

3. Income from investments
Bank interest
Investment interest
Unrestricted
Funds
£
13,846
29,473
43,319
Restricted
Funds
£
-
-
-
2025
Total
Funds
£
13,846
29,473
43,319
Unrestricted
Funds
£
1,172
20,776
21,948
Restricted
Funds
£
-
-
-
2024
Total
Funds
£
1,172
20,776
21,948

4. Raising funds expenditure

Fundraising and publicity
Other fundraising costs
Staff costs
Trading costs
Operating charity shops
Unrestricted
Funds
£
16,546
58,459
75,005
17,104
92,109
Restricted
Funds
£
120
-
120
192
312
2025
Total
Funds
£
16,666
58,459
75,125
17,296
92,421
Unrestricted
Funds
£
13,326
59,003
72,329
13,761
86,090
Restricted
Funds
£
37
-
37
5,606
5,643
2024
Total
Funds
£
13,363
59,003
72,366
19,367
91,733

Page 20

THE MARY HOW TRUST FOR CANCER PREVENTION

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

NOTES TO THE FINANCIAL STATEMENTS

5. Charitable activities

Unrestricted
Funds
£
Staff costs
472,642
Depreciation
12,925
Screening supplies
122,696
Accomodation costs
42,769
Insurance
9,524
Cleaning & medical waste disposal
11,421
Repairs to equipment
13,226
Printing, stationary, postage & telephone
2,123
Sundry
25,454
Screening
1,153
Bank interest and charges
1,173
Support costs (note 6)
5,589
Governance costs (note 7)
29,153
749,848
6. Support costs
Unrestricted
Funds
£
Staff costs
5,589
5,589
Restricted
Funds
£
-
-
1,293
-
-
-
-
-
597
-
-
-
1,890
Restricted
Funds
£
-
-
2025
Total
Funds
£
472,642
12,925
123,989
42,769
9,524
11,421
13,226
2,123
26,051
1,153
1,173
5,589
29,153
751,738
2025
Total
Funds
£
5,589
5,589
Unrestricted
Funds
£
395,287
12,805
120,745
40,423
7,640
10,491
15,659
1,795
21,986
3,449
1,568
16,599
23,031
671,478
Unrestricted
Funds
£
16,599
16,599
Restricted
Funds
£
-
-
2,878
-
-
-
-
-
-
-
-
-
-
2,878
Restricted
Funds
£
-
-
2024
Total
Funds
£
395,287
12,805
123,623
40,423
7,640
10,491
15,659
1,795
21,986
3,449
1,568
16,599
23,031
674,356
2024
Total
Funds
£
16,599
16,599

7. Governance costs

7. Governance costs
Staff costs
Accountancy fees
Legal and professional fees
Unrestricted
Funds
£
16,073
10,167
2,913
29,153
Restricted
Funds
£
-
-
-
-
2025
Total
Funds
£
16,073
10,167
2,913
29,153
Unrestricted
Funds
£
16,126
6,522
383
23,031
Restricted
Funds
£
-
-
-
-
2024
Total
Funds
£
16,126
6,522
383
23,031

8. Auditor's remuneration and examiner's fees

Auditor's remuneration - audit
Examiner's fees - examination
Payroll services
Unrestricted
Funds
£
6,600
324
2,880
9,804
Restricted
Funds
£
-
-
-
-
2025
Total
Funds
£
6,600
324
2,880
9,804
Unrestricted
Funds
£
-
3,600
2,922
6,522
Restricted
Funds
£
-
-
-
-
2024
Total
Funds
£
-
3,600
2,922
6,522

The charity's independent examiner also charged £363 during the year under review plus £468 in the comparative year for the provision of accountancy software.

Page 21

THE MARY HOW TRUST FOR CANCER PREVENTION

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

NOTES TO THE FINANCIAL STATEMENTS

9. Related party transactions

No trustees received any remuneration or other benefits, and no trustees expenses have been reimbursed by the charity in either the current or comparative year

Aggregate donations received from trustees during the year amounted to £728 (2024:£523)

Mrs S Ross, the wife of Mr J Ross, a representative on the board of trustees and the finance director, was employed as the lead shop manager and was paid £29,657 (2024: £28,988) in salary and pension.

During the year £456 was paid for marketing services to Scaramanga Marketing Limited for which the sole director is a trustee for the charity.

There are no further related party transactions during the financial year which require disclosure.

10. Wages and salary cost

Gross wages
Employer's national insurance costs (net of employment allowance)
Employer's pension contributions
Total payroll costs
Self employed clinicians
Self employed admin
Employer's pension contributions outside payroll
2025
Total
Funds
£
424,252
31,800
12,069
468,121
71,482
5,832
7,504
84,818
552,939
2024
Total
Funds
£
405,950
27,072
10,552
443,574
65,535
-
10,716
76,251
519,825

There were no employees with emoluments (excluding employer pension costs) above £60,000 in this or the preceding year

The average number of employees during the year was: 2025
19
19
2024
20
20

Key management personnel

A charity's key management personnel are those persons having authority and responsibility for planning, directing and controlling the activities of the charity, directly or indirectly. Employee benefits for the charity's key management personnel (as detailed in the information page) inclusive of gross pay, employer's national insurance and employer pension contributions amounted to £122,132 (2024: £111,159) in the year under review.

Page 22

THE MARY HOW TRUST FOR CANCER PREVENTION

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

NOTES TO THE FINANCIAL STATEMENTS

11. Tangible fixed assets

Cost
At 1 April 2024
Additions
On disposals
At 31 March 2025
Depreciation
Accumulated at 1 April 2024
Charge for the year
On disposals
At 31 March 2025
Net book value at 31 March 2025
Net book value at 31 March 2024
Leasehold
improvements
64,592
-
-
64,592
21,422
6,168
-
27,590
37,002
43,170
Plant &
equipment
77,127
-
-
77,127
63,854
6,633
-
70,487
6,640
13,273
Fixtures &
Fittings
£
480
381
-
861
480
127
-
607
254
-
Total
£
142,199
381
-
142,580
85,756
12,928
-
98,684
43,896
56,443

12. Fixed asset investments

Cost or valuation
At 1 April
Additions
Disposals
Valuation changes
At 31 March
Cash held in investments
Total fixed asset investment at 31 March
Listed
Investments
£
2025
604,565
1,132,908
(183,917)
7,287
1,560,843
3,037
1,563,880
Listed
Investments
£
2024
445,395
125,000
-
34,170
604,565
-
604,565

13. Debtors

13. Debtors
Trade debtors
Prepayments and accrued income
2025
Total
Funds
£
-
4,327
4,327
2024
Total
Funds
£
395
6,638
7,033

Page 23

THE MARY HOW TRUST FOR CANCER PREVENTION

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

NOTES TO THE FINANCIAL STATEMENTS

14. Current asset investments

14. Current asset investments
Short term deposits
15. Creditors: amounts falling due within one year
Trade creditors
Accruals and deferred income
Other taxation and social security
Other creditors
2025
Total
Funds
£
173,448
173,448
2025
Total
Funds
£
12,888
55,002
8,663
2,694
79,247
2024
Total
Funds
£
165,406
165,406
2024
Total
Funds
£
13,230
8,993
8,069
2,212
32,504

16. Analysis of net assets between funds

Tangible fixed assets
Investments
Current assets
Current liabilities
Unrestricted
Funds
£
43,896
1,563,880
268,782
(79,247)
1,797,311
Restricted
Funds
£
-
-
352
-
352
2025
Total
Funds
£
43,896
1,563,880
269,134
(79,247)
1,797,663
Unrestricted
Funds
£
56,443
604,565
352,591
(32,504)
981,095
Restricted
Funds
£
-
-
1,905
-
1,905
2024
Total
Funds
£
56,443
604,565
354,496
(32,504)
983,000

Page 24

THE MARY HOW TRUST FOR CANCER PREVENTION

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

NOTES TO THE FINANCIAL STATEMENTS

17. Analysis of net movement in funds
Total funds
brought
forward
£
Restricted funds
Billingshurst Lions
-
Bowerman Trust
192
Equipment for Room 3
-
Defibtech
-
Shanly Foundation
-
HDC LEAP Grant
-
HDC Lottery Grant
1,000
HDC Community Grant
500
HDC Big Help out
213
Billingshurst Parish Council
-
Total restricted funds
1,905
Unrestricted funds
Designated funds
Capacity extension
330,000
Clinical IT Upgrade
50,000
Short term investments
165,406
Fixed asset reserve
-
545,406
General Fund
435,689
Total unrestricted funds
981,095
Total funds
983,000
Total funds
brought
forward
£
Restricted funds
Billingshurst Lions
-
Bowerman Trust
-
Equipment for Room 3
-
Defibtech
-
Shanly Foundation
-
HDC LEAP Grant
-
HDC Lottery Grant
-
HDC Community Grant
-
HDC Big Help out
-
Total restricted funds
-
Unrestricted funds
Designated funds
Capacity extension
150,000
Clinical IT Upgrade
-
Short term investments
160,000
310,000
General Fund
408,337
Total unrestricted funds
718,337
Total funds
718,337
17. Analysis of net movement in funds
Total funds
brought
forward
£
Restricted funds
Billingshurst Lions
-
Bowerman Trust
192
Equipment for Room 3
-
Defibtech
-
Shanly Foundation
-
HDC LEAP Grant
-
HDC Lottery Grant
1,000
HDC Community Grant
500
HDC Big Help out
213
Billingshurst Parish Council
-
Total restricted funds
1,905
Unrestricted funds
Designated funds
Capacity extension
330,000
Clinical IT Upgrade
50,000
Short term investments
165,406
Fixed asset reserve
-
545,406
General Fund
435,689
Total unrestricted funds
981,095
Total funds
983,000
Total funds
brought
forward
£
Restricted funds
Billingshurst Lions
-
Bowerman Trust
-
Equipment for Room 3
-
Defibtech
-
Shanly Foundation
-
HDC LEAP Grant
-
HDC Lottery Grant
-
HDC Community Grant
-
HDC Big Help out
-
Total restricted funds
-
Unrestricted funds
Designated funds
Capacity extension
150,000
Clinical IT Upgrade
-
Short term investments
160,000
310,000
General Fund
408,337
Total unrestricted funds
718,337
Total funds
718,337
Year ended 31 Mar 2025 Year ended 31 Mar 2025 Year ended 31 Mar 2025
Total funds
brought
forward
£
-
192
-
-
-
-
1,000
500
213
-
1,905
330,000
50,000
165,406
-
545,406
435,689
981,095
983,000
Total
incoming
resources
£
-
-
-
-
-
-
-
-
-
645
645
-
-
-
-
-
1,650,890
1,650,890
1,651,535
Total
Transfers
Gains/(losses)
resources
between
on investment
expended
funds
assets
£
£
£
-
-
-
(192)
-
-
-
-
-
-
-
-
-
-
-
-
-
-
(1,000)
-
-
(500)
-
-
(217)
4
-
(293)
-
-
(2,202)
4
-
-
470,000
-
-
-
-
-
(165,406)
-
-
43,896
-
-
348,490
-
(841,957)
(348,494)
7,287
(841,957)
(4)
7,287
(844,159)
-
7,287
Year ended 31 Mar 2024
Total funds
carried
forward
£
-
-
-
-
-
-
-
-
-
352
352
800,000
50,000
-
43,896
893,896
903,415
1,797,311
1,797,663
Total funds
brought
forward
£
-
-
-
-
-
-
-
-
-
-
150,000
-
160,000
310,000
408,337
718,337
718,337
Total
incoming
resources
£
-
5,798
-
-
2,742
1,539
1,000
500
250
11,829
-
-
5,406
5,406
979,348
984,754
996,583
Total
resources
expended
£
-
(5,606)
-
-
(2,878)
-
-
-
(37)
(8,521)
-
-
-
-
(757,569)
(757,569)
(766,090)
Transfers
between
funds
£
-
-
-
-
136
(1,539)
-
-
-
(1,403)
180,000
50,000
-
230,000
(228,597)
1,403
-
Gains/(losses)
on investment
assets
£
-
-
-
-
-
-
-
-
-
-
-
-
-
-
34,170
34,170
34,170
Total funds
carried
forward
£
-
192
-
-
-
-
1,000
500
213
1,905
330,000
50,000
165,406
545,406
435,689
981,095
983,000

Page 25

THE MARY HOW TRUST FOR CANCER PREVENTION UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

NOTES TO THE FINANCIAL STATEMENTS

18. Description of funds

Billingshurt Lions This fund was used for the purchase of clinical equipment (ECG)
Bowerman Trust This fund was used for the purchase of a new EPOS system for the charity shop.
Equipment for room 3 This fund was usef for the purchase of clinical equipment for the kit-out of room 3
Defibtech This fund was used for the purchase of a defibrillator
Shanly Foundation This fund was used for the purchase of clinical equipment (ECG/trolley/electrodes)
HDC LEAP Grant This fund was used for the purchase of promotional materials. The transfer recognised within the
grant relates to the recongition of costs incurred during the previous financial period
HDC Lottery Grant This fund is to be used for the purchase of clinical equipment (bariatric scales/ measuring stick)
HDC Community Grant This fund is to be used to create more screening slots
HDC Big Help Out This fund was used for the purchase of promotional materials
Billingshurst Parish Council This fund is to be used for the purchase of clinical equipment (bariatric scales/ measuring stick)
Capacity Extension This fund is to be used for the purchase of a second site, in order to increase screening levels by
3,500 between 2025 - 2027
Clinical IT Upgrade This fund is to be used for the purpose of upgrading clinical IT software and systems

19. Operating lease commitments

At the reporting end date the charity had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:

Within one year
Between two and five years
In over five years
2025
£
33,087
106,499
28,197
167,783
2024
£
34,337
112,789
54,914
202,040

Page 26

THE MARY HOW TRUST FOR CANCER PREVENTION

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

NOTES TO THE FINANCIAL STATEMENTS

20. Comparative statement of financial activities
Note
INCOME AND ENDOWMENTS FROM:
Donations and legacies
1
Other trading activities
2
Investments
3
Total income and endowments
EXPENDITURE ON:
Raising funds
4
Charitable activities
5
Total expenditure
Net gains/(losses on investments)
12
Net Income/(expenditure)
Transfers between funds
17
Net movement in funds
RECONCILIATION OF FUNDS
Total funds brought forward
17
Total funds carried forward
17
Unrestricted
Funds
£
841,342
121,463
21,948
984,753
86,090
671,478
757,568
34,170
261,355
1,403
262,758
718,337
981,095
Restricted
Funds
£
11,829
-
-
11,829
5,643
2,878
8,521
-
3,308
(1,403)
1,905
-
1,905
2024
Total
Funds
£
853,171
121,463
21,948
996,582
91,733
674,356
766,089
230,493
264,663
-
264,663
718,337
983,000

Page 27